Consistent with prior work (5) where abatacept was more effective in seropositive RA patients with high anti-CCP levels, nine out of ten patients with ACR50 response had high baseline anti-CCP levels (>300 U/ml) and were double-positive for both anti-CCP and IgM RF (Table 1). This evidence concerns the gene CD40LG and rheumatoid arthritis.